Legofer (Iron Protein Succinylate)

Iron Protein Succinylate delivers elemental iron that is readily absorbed in the upper small intestine. Once absorbed, the iron is incorporated into hemoglobin and iron‑dependent enzymes, facilitating oxygen transport in the blood and supporting cellular processes essential for erythropoiesis and energy metabolism.

The appropriate dose of Legofer is determined by a qualified prescriber based on the patient’s iron deficiency severity, age, weight, and overall health status. Healthcare professionals tailor the regimen to achieve optimal correction of iron levels while minimizing potential side effects.

Safety data for Legofer in pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit profile for each individual, considering the importance of correcting maternal iron deficiency while monitoring for any potential effects on the fetus or infant.

To place an order, submit an enquiry on the Legofer product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with traditional ferrous salts such as ferrous sulfate, Iron Protein Succinylate offers a protein‑bound form that may improve gastrointestinal tolerability and provide more consistent iron absorption. Clinical choice depends on patient tolerance, severity of deficiency, and physician preference.

Legofer should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Legofer is taken orally, usually with water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing relative to meals or other medications to optimize absorption and reduce gastrointestinal discomfort.

The most serious risks include severe allergic reactions such as anaphylaxis, iron overload from excessive dosing, and rare cases of hypotension. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling, or a sudden drop in blood pressure.

Legofer should be avoided in individuals with known hypersensitivity to Iron Protein Succinylate or any component of the formulation. Caution is also advised for patients with active gastrointestinal bleeding, iron overload disorders, or those receiving medications that may interact significantly with oral iron.